Log In
Print
BCIQ
Print
Print this Print this
 

KAR4141

  Manage Alerts
Collapse Summary General Information
Company Karus Therapeutics Ltd.
DescriptionPhosphoinositide 3-kinase (PI3K) p110 delta inhibitors
Molecular Target Phosphoinositide 3-kinase (PI3K)
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today